|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Tempest Therapeutics, Inc (TPST) |
|
|
$1.06 0.00 (0.00%) as of 4:30 Fri 6/25
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
6,640,000 |
| Market
Cap: |
7.04(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$1.06 - $1.06 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Tempest Therapeutics is a biopharmaceutical company, focused on developing treatments for endocrine diseases. Co.'s three product candidates are: Livoletide (AZP-531), which is for the treatment Prader-Willi syndrome, a genetic endocrine disease usually characterized by hyperphagia, or insatiable hunger; nevanimibe (ATR-101), which is a potential treatment for patients with congenital adrenal hyperplasia, a monogenic adrenal disease that requires lifelong treatment with exogenous cortisol, often at high doses; and NK3R antagonist (MLE-301), which is a potential treatment of vasomotor symptoms commonly known as hot flashes and night sweats, in menopausal women.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-02-18 |
2023-11-17 |
2023-05-19 |
2022-05-19 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Aldrich Richard |
Director |
– • – |
2016-12-07 |
4 |
GD |
$0.00 |
$0 |
I/I |
200,000 |
0 |
|
- |
|
| Aldrich Richard |
Director |
– • – |
2016-12-07 |
4 |
GA |
$0.00 |
$0 |
D/D |
200,000 |
807,707 |
|
- |
|
| Kozin Marc D |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,353 |
25,776 |
|
- |
|
| Fisher Mary |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
698 |
9,697 |
|
- |
|
| Malley Thomas |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,850 |
181,363 |
|
- |
|
| Aldrich Richard |
Director |
– • – |
2016-09-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,483 |
607,707 |
|
- |
|
| Couturier Christophe |
Chief Financial Officer |
• – – |
2016-09-08 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,600 |
|
- |
|
| Kozin Marc D |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
1,859 |
24,423 |
|
- |
|
| Fisher Mary |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
959 |
8,999 |
|
- |
|
| Malley Thomas |
Director |
– • – |
2016-06-30 |
4 |
A |
$0.00 |
$0 |
D/D |
2,543 |
179,513 |
|
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-06-01 |
4 |
B |
$7.00 |
$2,975,000 |
I/I |
425,000 |
962,056 |
2.66 |
- |
|
| Malley Thomas |
Director |
– • – |
2016-06-01 |
4 |
A |
$7.00 |
$350,000 |
D/D |
50,000 |
176,970 |
|
- |
|
| Aldrich Richard |
Director |
– • – |
2016-06-01 |
4 |
B |
$7.00 |
$2,975,000 |
I/I |
425,000 |
962,056 |
2.1 |
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-05-18 |
4 |
B |
$7.86 |
$157,200 |
I/I |
20,000 |
537,056 |
2.66 |
- |
|
| Aldrich Richard |
Director |
– • – |
2016-05-18 |
4 |
B |
$7.86 |
$157,200 |
I/I |
20,000 |
537,056 |
2.1 |
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-05-17 |
4 |
B |
$7.56 |
$151,200 |
I/I |
20,000 |
517,056 |
2.66 |
- |
|
| Aldrich Richard |
Director |
– • – |
2016-05-17 |
4 |
B |
$7.56 |
$151,200 |
I/I |
20,000 |
517,056 |
2.1 |
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-05-16 |
4 |
B |
$7.69 |
$153,800 |
I/I |
20,000 |
497,056 |
2.66 |
- |
|
| Aldrich Richard |
Director |
– • – |
2016-05-13 |
4 |
B |
$7.06 |
$115,043 |
I/I |
16,295 |
477,056 |
2.1 |
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-05-13 |
4 |
B |
$7.06 |
$115,043 |
I/I |
16,295 |
477,056 |
2.66 |
- |
|
| Aldrich Richard |
Director |
– • – |
2016-05-12 |
4 |
B |
$6.72 |
$135,352 |
I/I |
19,800 |
460,761 |
2.1 |
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-05-12 |
4 |
B |
$6.72 |
$135,352 |
I/I |
19,800 |
460,761 |
2.66 |
- |
|
| Dipp Michelle |
Chief Executive Officer |
• • – |
2016-05-11 |
4 |
B |
$7.64 |
$152,800 |
I/I |
20,000 |
440,961 |
2.66 |
- |
|
| Aldrich Richard |
Director |
– • – |
2016-05-11 |
4 |
B |
$7.64 |
$152,800 |
I/I |
20,000 |
440,961 |
2.1 |
- |
|
| Chapman Paul W.d. |
Chief Operating Officer |
• – – |
2016-05-10 |
4 |
B |
$7.37 |
$22,847 |
D/D |
3,100 |
3,100 |
2.74 |
- |
|
227 Records found
|
|
Page 3 of 10 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
